Japan to Witness Highest Growth During Forecast Period

DUBLIN, Jan. 4, 2024 /PRNewswire/ — The “Global Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global Cartilage Repair/Cartilage Regeneration Market is projected to reach USD 2.8 Billion by … Read more

AESTHETIC MANAGEMENT PARTNERS AND COLLAGEN P.I.N. UNITE TO TRANSFORM MICRONEEDLING LANDSCAPE

CORDOVA, Tenn., Jan. 4, 2024 /PRNewswire/ — Aesthetic Management Partners (AMP) is pleased to announce a dynamic collaboration with Collagen P.I.N., a pioneering force in the realm of microneedling pen technology. Explore how the collaboration between AMP and Collagen P.I.N. is reshaping microneedling in the aesthetics industry & discover cutting-edge skincare solutions. Renowned for its efficacy, … Read more

Columbus Aesthetic and Plastic Surgery Notifies of Data Security Incident

UPPER ARLINGTON, Ohio, Dec. 31, 2023 /PRNewswire/ — Columbus Aesthetic and Plastic Surgery (“CAPS”) determined on December 22, 2023 that a recent data security incident may have impacted information belonging to certain patients. On September 22, 2023, CAPS identified suspicious activity within its network environment, and promptly took steps to secure the environment and launch … Read more

CompleteCare Health Network Provides Notice of Cybersecurity Incident

SI DESEA RECIBIR ESTE AVISO EN ESPAÑOL, POR FAVOR MARQUE [856-451-4700]. GRACIAS BRIDGETON, N.J., Dec. 15, 2023 /PRNewswire/ — CompleteCare Health Network (CCHN) is providing notice of a recent cybersecurity incident that involved certain individuals’ personal identifiable information and personal health information. On or around October 12, 2023, CCHN detected and stopped a sophisticated ransomware … Read more

Sex Toys Market size in Japan to increase by USD 896.56 million between 2022 to 2027, Online Distribution Channel to be the major contributing segment

NEW YORK, Dec. 15, 2023 /PRNewswire/ — The sex toys market in Japan size is expected to grow by USD 896.56 million from 2022 to 2027, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 10.11% during the forecast period. Increasing cases of ED leading to the adoption of … Read more

LIFEbeat The Music Industry Fights AIDS TO BECOME A PROGRAM OF THE ELIZABETH TAYLOR AIDS FOUNDATION

LOS ANGELES, Dec. 13, 2023 /PRNewswire/ — The Elizabeth Taylor AIDS Foundation (ETAF) announced today that LIFEbeat will become a program of The Elizabeth Taylor AIDS Foundation. LIFEbeat mobilizes the music and entertainment industry to provide sexual health resources, including HIV, at music tours, special events, with broadcast, social media, and print campaigns. LIFEbeat engages … Read more

Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches

 Findings suggest “less is more” and “tried and true” may benefit select patients SAN DIEGO, Dec. 10, 2023 /PRNewswire/ — Research findings being presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition highlight new treatment approaches that are enabling patients to live longer or better, judicious uses of older treatment approaches, … Read more

REAGILA: An Atypical Antipsychotic Used in the Treatment of Schizophrenia and Manic or Mixed Episodes of Bipolar Disorder

DUBLIN, Dec. 8, 2023 /PRNewswire/ — The “REAGILA Drug Insight and Market Forecast – 2032” drug pipelines has been added to  ResearchAndMarkets.com’s offering. This report provides comprehensive insights about REAGILA for schizophrenia in the seven major markets. A detailed picture of the REAGILA for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and … Read more

University of Maryland and BioGenCell Announce the Launch of BioGenCell Fifth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States

BioGenCell has announced the inauguration of the fifth Phase II cell-therapy-based clinical trial site for Chronic Limb-Threatening Ischemia (CLTI) in the United States at the University of Maryland, Baltimore. This initiative is committed to dramatically reducing the incidence of amputations in patients afflicted with severe CLTI. BALTIMORE, Dec. 7, 2023 /PRNewswire/ — BioGenCell, a pioneer … Read more

Danaher Announces Quarterly Dividend

WASHINGTON, Dec. 5, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.24 per share of its common stock, payable on January 26, 2024 to holders of record on December 29, 2023. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics … Read more